Gallagher John E 4

4 · CONMED Corp · Filed Jul 17, 2026

AI-generated summary of this filing

Updated Jul 17, 2026

CONMED (CNMD) CFO John Gallagher Receives Award of 92,465 Shares

What Happened

John E. Gallagher, Executive Vice President & CFO of CONMED Corporation (CNMD), received three equity awards on July 15, 2026 totaling 92,465 derivative shares (35,054 + 26,875 + 30,536). Each award shows an acquisition price of $0, indicating compensation grants (not open-market purchases or sales). These awards were reported on a Form 4 filed July 17, 2026.
The awards include restricted stock units (RSUs) and stock options granted under CONMED’s 2025 Long-Term Incentive Plan. No shares were sold or exercised in this filing—this is a grant/compensation event rather than an investment purchase.

Key Details

Transaction date: 2026-07-15; Form 4 filed: 2026-07-17 (timely filing).
Award amounts: 35,054; 26,875; and 30,536 shares — total 92,465 derivative shares. Reported acquisition price: $0.00 (award).
Vesting (per footnotes):
- RSUs: generally vest over three years (33% at 1 year, 33% at 2 years, 34% at 3 years).
- Stock options: generally vest in equal amounts over four years (25% at 1 year, then quarterly/annually thereafter as specified).
Shares owned after transaction: not provided in the supplied excerpt.
No 10b5-1 plan, tax-withholding sale, cashless exercise, or late-filing flag was indicated in the provided details.

Context

These awards are standard long-term incentive compensation for executives and are common as retention and performance incentives; they do not represent a market purchase by the insider. RSUs are a contingent right to receive shares upon vesting; stock options give the right to buy shares if and when vested and exercised (exercise price not specified in the excerpt).
For retail investors, awards signal company compensation decisions but are not a straightforward bullish/bearish signal like a direct purchase or sale.

Form 4

Period: 2026-07-15

Executive Vice President & CFO

Transactions

Award
RSUs (Restricted Stock Units)
[F1]
2026-07-15+35,054→ 35,054 total
Exercise: $0.00Exp: 2036-07-15→ Common Stock (35,054 underlying)
Award
RSUs (Restricted Stock Units)
[F1]
2026-07-15+26,875→ 61,929 total
Exercise: $0.00Exp: 2036-07-15→ Common Stock (26,875 underlying)
Award
Options To Purchase Common Stock
[F2]
2026-07-15+30,536→ 30,536 total
Exercise: $42.79Exp: 2036-07-15→ Common Stock (30,536 underlying)

Footnotes (2)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
[F2]The stock options were granted under CONMED Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

Signature

/s/ Thomas Fistek for John Gallagher by Power of Attorney|2026-07-17

1 file